BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 467815)

  • 21. Effect of stopping low-phenylalanine diet on intellectual progress of children with phenylketonuria.
    Smith I; Lobascher ME; Stevenson JE; Wolff OH; Schmidt H; Grubel-Kaiser S; Bickel H
    Br Med J; 1978 Sep; 2(6139):723-6. PubMed ID: 698696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Disease course in 20 patients with an early diagnosis of phenylketonuria and hyperphenylalaninemia].
    Schwarz HP; Plüss C; Triaca H; Schütz B; Kaufmann R; Scherz R; Bachmann C; Zuppinger K
    Schweiz Med Wochenschr; 1988 Jan; 118(3):94-9. PubMed ID: 3344414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability of blood phenylalanine levels and IQ in children with phenylketonuria.
    Anastasoaie V; Kurzius L; Forbes P; Waisbren S
    Mol Genet Metab; 2008; 95(1-2):17-20. PubMed ID: 18703366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Austrian report on longitudinal outcome in phenylketonuria.
    Scheibenreiter S; Tiefenthaler M; Hinteregger V; Strobl W; Mühl A; Ewald A; Schadler M
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S45-9. PubMed ID: 8828608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intelligence in mild atypical phenylketonuria.
    Costello PM; Beasley MG; Tillotson SL; Smith I
    Eur J Pediatr; 1994 Apr; 153(4):260-3. PubMed ID: 8194559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term follow-up of patients treated for phenylketonuria (PKU). Results from the Prague PKU Center.
    Cechák P; Hejcmanová L; Rupp A
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S59-63. PubMed ID: 8828612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of intelligence in early treated phenylketonuria.
    Burgard P
    Eur J Pediatr; 2000 Oct; 159 Suppl 2():S74-9. PubMed ID: 11043149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intellectual development of patients with phenylketonuria; 15-year national screening in The Netherlands].
    Huisman J; van der Schot LW; Hendrikx MM; Kalverboer AF; Slijper FM
    Ned Tijdschr Geneeskd; 1992 Nov; 136(46):2277-81. PubMed ID: 1461293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term development of intelligence (IQ) and EEG in 34 children with phenylketonuria treated early.
    Pietz J; Benninger C; Schmidt H; Scheffner D; Bickel H
    Eur J Pediatr; 1988 May; 147(4):361-7. PubMed ID: 3396592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early-treated phenylketonuria: neuropsychologic consequences.
    Brunner RL; Jordan MK; Berry HK
    J Pediatr; 1983 Jun; 102(6):831-5. PubMed ID: 6854445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of life and adherence to treatment in early-treated Brazilian phenylketonuria pediatric patients.
    Vieira E; Maia HS; Monteiro CB; Carvalho LM; Tonon T; Vanz AP; Schwartz IVD; Ribeiro MG
    Braz J Med Biol Res; 2017 Dec; 51(2):e6709. PubMed ID: 29267500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
    Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
    Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wechsler subscale IQ and subtest profile in early treated phenylketonuria.
    Griffiths PV; Demellweek C; Fay N; Robinson PH; Davidson DC
    Arch Dis Child; 2000 Mar; 82(3):209-15. PubMed ID: 10685922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect on intelligence of relaxing the low phenylalanine diet in phenylketonuria.
    Smith I; Beasley MG; Ades AE
    Arch Dis Child; 1991 Mar; 66(3):311-6. PubMed ID: 2025007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The IQ of heterozygotes for phenylketonuria (PKU). indication of a blood phenylalanine-independent action of the PKU mutant (author's transl)].
    Thalhammer O; Havelec L; Knoll E; Wehle E
    Wien Klin Wochenschr; 1977 Oct; 89(20):684-6. PubMed ID: 930099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychiatric disorders in adult patients with early-treated phenylketonuria.
    Pietz J; Fätkenheuer B; Burgard P; Armbruster M; Esser G; Schmidt H
    Pediatrics; 1997 Mar; 99(3):345-50. PubMed ID: 9041285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transitory hyperphenylalaninaemia in children with continuously treated phenylketonuria.
    Griffiths P; Smith C; Harvie A
    Am J Ment Retard; 1997 Jul; 102(1):27-36. PubMed ID: 9241405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment variables and intellectual outcome in children with classic phenylketonuria. A single-center-based study.
    Legido A; Tonyes L; Carter D; Schoemaker A; Di George A; Grover WD
    Clin Pediatr (Phila); 1993 Jul; 32(7):417-25. PubMed ID: 8365077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intellectual assessment of 111 four-year-old children with phenylketonuria.
    Dobson JC; Williamson ML; Azen C; Koch R
    Pediatrics; 1977 Dec; 60(6):822-7. PubMed ID: 600594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of intelligence quotient and intelligence quotient change in persons treated for phenylketonuria early in life.
    Waisbren SE; Mahon BE; Schnell RR; Levy HL
    Pediatrics; 1987 Mar; 79(3):351-5. PubMed ID: 3822635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.